Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review
EXCLI Journal · 08.09.2025 · 24 · 1225-1261
DOI: 10.17179/excli2025-8771 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift EXCLI Journal, online erschienen am 08.09.2025. Verfasst von Haoxuan Cheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Berberine (BBR) is a plant-derived alkaloid that has been traditionally used in Chinese medicine to treat diarrhea. In recent years, accumulating evidence has highlighted its broad therapeutic potential across multiple organ systems. This review systematically examines the pharmacological mechanisms and therapeutic applications of BBR in cancer, as well as in digestive, metabolic, cardiovascular, and neurological diseases. The effects of BBR on endogenous factors—such as energy metabolism, immune responses, cellular homeostasis, and gene expression—are discussed, along with its regulation of cellular functions and inflammatory responses. In addition, we explore BBR’s actions on exogenous factors, particularly the gut microbiota. The review also summarizes emerging molecular targets of BBR and addresses current clinical applications, as well as novel strategies to improve its low oral bioavailability. By integrating findings from basic, translational, and clinical research, this review provides a comprehensive overview of BBR’s therapeutic potential and supports its integration into modern medical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
- Department of Laboratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Cheng, H., Li, X., Wang, Y., Deng, W., Sun, G., Zhang, D., Hao, J., & Liu, X. (2025). Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review. EXCLI Journal, 24, 1225-1261. https://doi.org/10.17179/excli2025-8771
Vancouver
Cheng H, Li X, Wang Y, Deng W, Sun G, Zhang D, et al. Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review. EXCLI Journal. 2025;24:1225-1261. doi:10.17179/excli2025-8771
BibTeX
@article{Cheng2025,
author = {Cheng, Haoxuan and Li, Xinyu and Wang, Yanqi and Deng, Wanqing and Sun, Guangyong and Zhang, Dong and Hao, Jianyu and Liu, Xinjuan},
title = {Berberine pharmacological properties and therapeutic potential across cancer, digestive, metabolic, cardiovascular, and neurological diseases: an update review},
journal = {EXCLI Journal},
year = {2025},
volume = {24},
pages = {1225--1261},
doi = {10.17179/excli2025-8771}
}
EUVIMED